News Release

• May 16, 2019

  Announcement of a Strategic Capital and Business Alliance Agreement with Fidson Healthcare Plc.
• May 9, 2019

  Patent Assignment Agreement on Novel Sarcoma Treatment
• April 26, 2019

  Announcement of the signing of a joint R & D agreement and commencement of development activities regarding“Research and development of innovative antifibrotic drugs to improve the life prognosis of cirrhosis”
• April 25, 2019

  License and Joint Development Agreement on Novel Biliary Tract Cancer Treatment
• February 15, 2019

  License Agreement on Novel Gliomas Treatment (PDF: 123KB)
• December 20, 2018

  Novel development drug OP-724 (PRI-724) for the treatment of cirrhosis is published on Nature Outline (PDF: 152KB)
• November 14, 2018

  A development project for a novel therapeutic agent for liver cirrhosis was adopted as the Cyclic Innovation for Clinical Innovation for Clinical Empowerment(CiCLE) by the Japan Agency for Medical Research and Development(AMED) (PDF: 188KB)
• June 21, 2018

  Ohara has entered into license agreement with PRISM on novel liver cirrhosis treatment (PDF: 116KB)
• September 13, 2017

  A Cooperative Research Study with the National Cancer Center Japan (PDF: 1.03MB)